Identification
Personal identification
- Full name
- Adelaide Fernandes
Citation names
- Fernandes, Adelaide
Author identifiers
- Ciência ID
- 2F17-4BE1-A074
- ORCID iD
- 0000-0002-2782-9519
Languages
Language | Speaking | Reading | Writing | Listening | Peer-review |
---|---|---|---|---|---|
English | Advanced (C1) | Advanced (C1) | Advanced (C1) | Advanced (C1) |
Education
Degree | Classification | |
---|---|---|
2006
Concluded
|
Pharmacy (Doutoramento)
Universidade de Lisboa Faculdade de Farmácia, Portugal
"Mechanisms of astrocyte inflammatory response to UCB and modulation by immunosuppressive therapy" (THESIS/DISSERTATION)
|
Unanimous summa cum laude |
2002
Concluded
|
Pharmaceutical Sciences (Licenciatura)
Universidade de Lisboa Faculdade de Farmácia, Portugal
|
16 (dezasseis) valores |
Affiliation
Science
Category Host institution |
Employer | |
---|---|---|
2015 - Current | Principal Investigator (Research) | Universidade de Lisboa Instituto de Investigação do Medicamento, Portugal |
Teaching in Higher Education
Category Host institution |
Employer | |
---|---|---|
2023/07/01 - Current | Associate Professor (University Teacher) | Universidade de Lisboa Faculdade de Farmácia, Portugal |
Universidade de Lisboa Faculdade de Farmácia, Portugal | ||
2010/12/01 - 2023/06/30 | Assistant Professor (University Teacher) | Universidade de Lisboa Faculdade de Farmácia, Portugal |
Universidade de Lisboa Faculdade de Farmácia, Portugal |
Others
Category Host institution |
Employer | |
---|---|---|
2009/07/01 - 2010/11/30 | Research Assistant C2008-FFUL-UBMBE-02-2008, Ciência 2008. | Universidade de Lisboa Instituto de Investigação do Medicamento, Portugal |
2006/10/01 - 2009/06/30 | Postdoctoral student (SFRH/BPD/26390/2006) | Universidade de Lisboa Faculdade de Farmácia, Portugal |
2002/10/01 - 2006/09/30 | PhD Student | Universidade de Lisboa Faculdade de Farmácia, Portugal |
2002/04/01 - 2002/09/30 | Research Fellow | Universidade de Lisboa Faculdade de Farmácia, Portugal |
1999/09/01 - 2001/09/30 | Trainee student | Universidade de Lisboa Faculdade de Farmácia, Portugal |
Projects
Grant
Designation | Funders | |
---|---|---|
2024/01/01 - 2025/12/01 | Microbiome manipulation to reduce psychopathology in Multiple Sclerosis
BiocodexMicrobiota 2024
Principal investigator
Universidade de Lisboa Instituto de Investigação do Medicamento, Portugal
|
Biocodex Microbiota Foundation
Ongoing
|
2022/01 - 2024/12 | Análise da desregulação neuroimmune na doença de Alzheimer para uma terapia com miRNAs veiculados por exosomas
Provided by PTCRIS: PTDC/MED-NEU/2382/2021
Researcher
|
Fundação para a Ciência e a Tecnologia |
2022/01 - 2024/12 | A interação entre a resposta imune inata e a adquirida como base do defice cognitivo presente na Esclerose Múltipla
Provided by PTCRIS: PTDC/MED-PAT/2582/2021
Principal investigator
|
Fundação para a Ciência e a Tecnologia |
2022/01 - 2023/12 | A interação da microglia e das células T na base da excessiva eliminação de sinapses associada ao défice cognitivo na Esclerose
Múltipla
688273478011411110311497109973280698383796547202109209472022DRI
Principal investigator
|
Fundação para a Ciência e a Tecnologia |
2020/01 - 2023/12 | Instituto de Investigação do Medicamento
Provided by PTCRIS: UIDP/04138/2020
Researcher
|
Fundação para a Ciência e a Tecnologia |
2020/01 - 2023/12 | Instituto de Investigação do Medicamento
Provided by PTCRIS: UIDB/04138/2020
Researcher
|
Fundação para a Ciência e a Tecnologia |
2022/01 - 2023/06 | Papel da obesidade na esclerose múltipla: identificação de microRNAs relacionados com o desenvolvimento dos oligodendrócitos
como novos alvos terapêuticos para promover a remielinização
Provided by PTCRIS: EXPL/MED-NEU/1033/2021
Researcher
|
Fundação para a Ciência e a Tecnologia |
2022 - 2023 | Unraveling the role of glial cells in ARSACS
ARSACS2022
Co-Principal Investigator (Co-PI)
Universidade de Lisboa Instituto de Investigação do Medicamento, Portugal
|
Ataxia Canada
Concluded
|
2018/10 - 2022/09 | Novas Substâncias Psicoativas, Cérebro e Adolescência - Uma Plataforma de Avaliação de Risco
Provided by PTCRIS: PTDC/SAU-TOX/32515/2017
Researcher
|
Fundação para a Ciência e a Tecnologia |
2018/09 - 2022/08 | Detetar, prevenir, erradicar: uma estratégia concertada para combater a metastização do cancro da mama para o encéfalo
Provided by PTCRIS: PTDC/MED-ONC/29402/2017
Researcher
|
Fundação para a Ciência e a Tecnologia |
2018/08 - 2022/08 | Desenvolvimento de uma terapia para uso de exosomas autólogos após modulação de microRNAs em microglia e neurónios-motores
recorrendo a modelos animais e humanos de esclerose lateral amiotrófica ELA
Provided by PTCRIS: PTDC/MED-NEU/31395/2017
Researcher
|
Fundação para a Ciência e a Tecnologia |
2018/07/01 - 2021/06/30 | Targeting multiple sclerosis immune- and psycho-pathophysiology by modulation of neuroinflammation
GMSI2017
Principal investigator
Universidade de Lisboa Instituto de Investigação do Medicamento, Portugal
|
Merck KGaA
Ongoing
|
2019/01 - 2019/12 | Instituto de Investigação do Medicamento
Provided by PTCRIS: UID/DTP/04138/2019
Researcher
|
Fundação para a Ciência e a Tecnologia |
2018/09 - 2019/09 | New molecules to characterize & treat demyelinating lesions - MyelinBASHY
YiMed-2018
Principal investigator
Universidade de Lisboa Instituto de Investigação do Medicamento, Portugal
|
Concluded
|
2016/01 - 2019/06 | Geração de modelos celulares e animais aperfeiçoados para identificação do fenótipo e de novos alvos terapêuticos na Doença
de Alzheimer
Provided by PTCRIS: JPCOFUND/0003/2015
Researcher
|
Fundação para a Ciência e a Tecnologia |
2017 - 2019 | Identification and assessment of new psychoactive substances: a European network - co-funded by the European Union
HOME/2014/JDRU/AG/DRUG/7086
Researcher
Universidade de Lisboa Instituto de Investigação do Medicamento, Portugal
|
Concluded
|
2015/01 - 2018/12 | Instituto de Investigação do Medicamento
Provided by PTCRIS: UID/DTP/04138/2013
Researcher
|
Fundação para a Ciência e a Tecnologia |
2015 - 2018 | Development of a European network for preclinical testing of interventions in mouse models of age and age-related diseases
(MouseAGE)
COST Action BM1402
Researcher
Universidade de Lisboa Instituto de Investigação do Medicamento, Portugal
|
Concluded
|
2014/03 - 2015/08 | Decrifrar como os microRNAs regulam o fenótipo da microglia na Doença de Alzheimer
Provided by PTCRIS: EXPL/NEU-NMC/1003/2013
Researcher
|
Fundação para a Ciência e a Tecnologia |
2012/01 - 2015/07 | SERÁ A MICROGLIA UM NOVO ALVO FARMACOLÓGICO COM POTENCIAL INTERESSE NA ESCLEROSE LATERAL AMIOTRÓFICA ELA?
Provided by PTCRIS: PTDC/SAU-FAR/118787/2010
Researcher
|
Fundação para a Ciência e a Tecnologia |
2014/03 - 2015/02 | Decoding the regulation of microglia phenotype by microRNAs in Alzheimer's Disease
Principal investigator
|
Fundação para a Ciência e a Tecnologia, I.P. |
2014/02 - 2014/09 | LisbonLiving+: Innovative strategies for a healthy life and an active ageing in the Region of Lisbon
Researcher
|
Fundação para a Ciência e a Tecnologia, I.P. |
2013/10 - 2014/09 | Role of S100B in multiple sclerosis: from a biomarker to a therapeutic target
Ordem Farmaceuticos2013
Principal investigator
Universidade de Lisboa Instituto de Investigação do Medicamento, Portugal
|
Ordem dos Farmaceuticos
Concluded
|
2011/01 - 2013/12 | Projecto Estratégico - UI 4013 - 2011-2012
123298UID
Researcher
|
Fundação para a Ciência e a Tecnologia |
2007/07 - 2011/04 | Estudo da perturbação da barreira hemato-encefálica por neurotoxinas e modulação por agentes terapêuticos num modelo humano:
efeitos da bilirrubina e da endotoxina em células endoteliais de capilares cerebrais e acção protectora de ácidos biliares
Provided by PTCRIS: PTDC/SAU-FCF/68819/2006
Researcher
|
Fundação para a Ciência e a Tecnologia |
2007/07 - 2010/12 | À descoberta de potenciais alterações de neurodesenvolvimento em situações comuns no período neonatal, tais como na hiperbilirrubinemia
e na inflamação
Provided by PTCRIS: PTDC/SAU-NEU/64385/2006
Researcher
|
Fundação para a Ciência e a Tecnologia Fundação para a Ciência e a Tecnologia, I.P. |
2007/01 - 2009/07 | Acute and long-term injury of bilirubin to nerve cells - Looking for sensors, susceptibilities and modulators
Researcher
|
Fundação para a Ciência e a Tecnologia, I.P. |
2006/10 - 2009/06 | MODULATION OF GROWTH CONE BEHAVIOR AND AXONAL CONNECTIONS FORMATION IN DEVELOPING NERVOUS SYSTEM BY TOXICANTS POTENTIALLY
RELATED WITH SCHIZOPHRENIA
Provided by PTCRIS: SFRH/BPD/26390/2006
Post-doc Fellow
|
Fundação para a Ciência e a Tecnologia |
2005/09 - 2008/06 | Lesão cerebral pela bilirrubina e impacto nas doenças neurodegenerativas - À procura de sensores, susceptilidades e moduladores
Provided by PTCRIS: POCI/SAU-MMO/55955/2004
PhD Student Fellow
|
Fundação para a Ciência e a Tecnologia |
2002/10 - 2006/09 | RESPOSTA INFLAMATÓRIA DAS CÉLULAS NERVOSAS A AGENTES NEUROTÓXICOS COMO A BILIRRUBINA, A ENDOTOXINA E A AMÓNIA. MODULAÇÃO PELA
VITAMINA-E E IL-10
Provided by PTCRIS: SFRH/BD/9204/2002
PhD Student Fellow
|
Fundação para a Ciência e a Tecnologia |
Contract
Designation | Funders | |
---|---|---|
2023/07/01 - 2028/06/30 | SIMPATHIC - Accelerating drug repurposing for rare neurological, neurometabolic and neuromuscular disorders by exploiting
SIMilarities in clinical and molecular PATHology
SYMPATHIC
Researcher
Universidade de Lisboa Faculdade de Farmácia, Portugal
|
European Research Executive Agency
Ongoing
|
2015 - 2016 | Evaluation of the impact of ingredients on myelination markers in an ex vivo cerebellar slice culture mode
Nestle2014
Principal investigator
Universidade de Lisboa Instituto de Investigação do Medicamento, Portugal
|
Nestlé Lausanne
Concluded
|
Outputs
Publications
Book chapter |
|
Journal article |
|
Other
Other output |
|
Activities
Oral presentation
Presentation title | Event name Host (Event location) |
|
---|---|---|
2023/12/01 | Participar de Corpo Inteiro | 18º Congresso Nacional de Esclerose Multipla
SPEM (Evora, Portugal)
|
2023/06/26 | Exploring the impact and CD8 T cells interplay in Multiple Sclerosis | 14th iMed.ULisboa Postgraduate Students Meeting
iMed (Lisboa, Portugal)
|
2023/05/01 | Microglia and T cells: the dark side of cognitive impairment in multiple sclerosis | European Neuroscience Conference by Doctoral Students (ENCODS 2023)
ENCODS (Faro, Portugal)
|
2022/12/03 | O que significa Atrasar a EM? | 17ª edição do Congresso Nacional da Esclerose Múltipla (CNEM)
SPEM (Lisboa, Portugal)
|
2022/10/18 | Alterations in CNS Pathogenesis of the In Vivo Model of Multiple Sclerosis: Age Impact. | VI Symposium of the Portuguese Glial Network
(Porto, Portugal)
|
2022/07/05 | The impact of age in the in vivo model of Multiple Sclerosis: insights in overall health, spinal cord pathology and gut microbiome. | 13th iMed.ULisboa Posgraduate Students Meeting
(Lisboa, Portugal)
|
2022/02/11 | The impact of age in the glial-immune interplay using the in vivo model of Multiple Sclerosis | 52nd Meeting of the Portuguese Society of Pharmacology/40th Clinical Pharmacological Meeting/21st Toxicology Meeting
Portuguese Society of Pharmacology (Porto, Portugal)
|
2021/02/19 | THE CELLULAR PLAYERS INTERVENING IN CEREBRAL ISCHEMIA-REPERFUSION INJURY ASSOCIATED WITH STROKE | Sociedade Portuguesa de Farmacologia - Annual Meeting 2021
Sociedade Portuguesa de Farmacologia (Lisbon, Portugal)
|
2021/02/19 | A NEW PHARMACOLOGICAL APPROACH TO PREVENT SYNAPTIC LOSS AND PROMOTE MYELIN PHAGOCYTOSIS: A STEP FORWARD TO MODULATE COGNITIVE IMPAIRMENT AND REMYELINATION IN MS | Sociedade Portuguesa de Farmacologia - Annual Meeting 2021
Sociedade Portuguesa de Farmacologia (Lisbon, Portugal)
|
2021/02/19 | PENTAMIDINE PREVENTS MULTIPLE SCLEROSISLIKE PATHOGENESIS BY NEUTRALIZING S100B TOXIC EFFECTS | Sociedade Portuguesa de Farmacologia - Annual Meeting 2021
Sociedade Portuguesa de Farmacologia (Lisbon, Portugal)
|
2021/02/19 | IMPROVED FRAILTY INDEX SCALE IN IN VIVO MODEL OF MULTIPLE SCLEROSIS: A NOVEL APPROACH TO BETTER UNDERSTAND PHENOTYPIC ALTERATIONS IN DISTINCT MICE- AGED | Sociedade Portuguesa de Farmacologia - Annual Meeting 2021
Sociedade Portuguesa de Farmacologia (Lisbon, Portugal)
|
2021/02/18 | DOES A SINGLE BINGE DOSING OF 4-CLOROETHCATHINONE (4-CEC) IMPAIR LEARNING AND MEMORY ABILITIES IN YOUNG MICE? | Sociedade Portuguesa de Farmacologia - Annual Meeting 2021
Sociedade Portuguesa de Farmacologia (Lisbon, Portugal)
|
2021/02/18 | NANOBODY-BASED STRATEGIES TO TARGET S100B AND IMPROVE RECOVERY IN AN EX VIVO DEMYELINATING MODEL | Sociedade Portuguesa de Farmacologia - Annual Meeting 2021
Sociedade Portuguesa de Farmacologia (Lisbon, Portugal)
|
2020/09 | Pentamidine as a new therapeutic strategy against Multiple Sclerosis-like pathology | 8th Joint ACTRIMS-ECTRIMS Meeting
ECTRIMS-ACTRIMS (Washington, United States)
|
2020/01/24 | Neuronal miR-124 modulation as a dual-front approach in AD: Benefits for neuronal homeostasis and paracrine microglia immunomodulation. | Meeting Juntos pelo Fernando, Faculty of Medicine
University of Lisbon (Lisboa, Portugal)
|
2019/11 | Microglia: responders or inducers of neurodegenerative disorders | CNC Seminars
Universidade de Coimbra (Coimbra, Portugal)
|
2019/10 | Human iPSC-derived astrocytes as a model to study neuroinflammation and implications on cell to cell trafficking | 1th International Meeting of Portuguese Society for Stem Cells and Cell Therapies
Portuguese Society for Stem Cells and Cell Therapies (Lisboa, Portugal)
|
2019/10 | Neuroinflammation and neurodegeneration – a gliocentric perpective | 33rd Meeting for the Study Group of Cerebral Aging and Dementia
Study Group of Cerebral Aging and Dementia (Curia, Portugal)
|
2019/09 | S100B as a biomarker and therapeutic target in Multiple Sclerosis | ESN Biennial Meeting - 7th Conference on Molecular Mechanisms of Regulation in the Nervous System
ESN Biennial Meeting (Milan, Italy)
|
2019/09 | Interplay between glial-immune cells in multiple sclerosis | 18th National Meeting of the Spanish Neuroscience Society (SENC),
18th National Meeting of the Spanish Neuroscience Society (SENC), (Santiago de Compostela, Spain)
|
2019/05/30 | S100B has crucial role in neuroinflammation and immune response in the in vivo model of Multiple Sclerosis. | XIV Meeting of the Portuguese Society for Neuroscience (SPN)
Portuguese Society for Neuroscience (SPN) (Lisboa, Portugal)
|
2019/05/29 | Immunomodulation of microglia inflammatory repertoire by dynamic miR-124 signature of APP-Swe neuronal cells. | IV Symposium of the Portuguese Glial Network
Portuguese Glial Network (Lisboa, Portugal)
|
2019/05 | Microglia: much more than M1 and M2 phenotypes | IV Symposium of the Portuguese Glial Network
Portuguese Glial Network (Lisboa, Portugal)
|
2019/03/26 | Morphological and inflammatory aberrancies in homogeneous and heterogeneous populations of human astrocytes generated from AD-iPSCs and consequences in exosomal cargo | 14th International Conference on Alzheimer's and Parkinson's Diseases (AD/PD 2019)
(Lisboa, Portugal)
|
2019/03/26 | Overexpression of mir-124 in APP-Swe cells is a protective mechanism to maintain their morphology and reduce exosomal inflammatory-miRNA cargo. | 14th International Conference on Alzheimer's and Parkinson's Diseases (AD/PD)
(Lisboa, Portugal)
|
2019/02/14 | Targeting S100B prevents in vivo Multiple Sclerosis-like pathology. | 5th International Porto Congress of Multiple Sclerosis
(Porto, Portugal)
|
2019/01 | Relevance of neuroinflammation in demyelinating disorders: from pathogenesis to therapeutic targeting. | Chemistry Biology Crosstalks
Department of Chemistry, Faculdade de Farmácia, Universidade de Lisboa (Lisboa, Portugal)
|
2018/06 | Neuroinflammation in Mutiple Sclerosis: from target discovery to development of a therapeutic strategy | Seminários CNC
(coimbra, Portugal)
|
2018/03 | Multiple sclerosis: a journey from target discovery to therapeutic strategy assay. | 9th AIMS - Annual International Medical Students Meeting.
(Lisbo, Portugal)
|
2018/02 | Exosomes from SH-APPSwe cells recapitulate their microRNA profile and trigger microglial autophagic dysfunction | XLVIII Reunião Anual da Sociedade Portuguesa de Farmacologia
Faculty of Medicine of the University of Lisbon (Lisboa, Portugal)
|
2017/11 | Role of astrocyte activation in demyelination. ongress of Portuguese society of Neurology. Lisboa, Portugal, Nov 16-18, 2017.C | Congress of Portuguese society of Neurology.
(lis, Portugal)
|
2017/05 | Glia interplay during demyelination. | II Symposium – Portuguese Glial Network. Glial cells: much more than glue. ICVS/3B’s,
(Braga , Portugal)
|
2016/11 | Targeting in situ neuroinflammation in MS. | 6th Annual Meeting Frontiers in Neurology (FIN6). Trinity College Dublin,
(Dublin, Ireland)
|
2016/11 | Tackling neuroinflammation in multiple sclerosis. | I Symposium – Portuguese Glial Network. ICVS/3B’s,
(Braga, Portugal)
|
2016/06 | Neuron-glial interplay during neurodevelopment and neurodegenerative disorders. | Understanding the Molecular Brain in Health and Disease Simposium. Faculdade Ciências Universidade Lisboa,
(lisbo, Portugal)
|
2015/11 | Tackling S100B as a new player in Multiple Sclerosis. | I Congress in Health Sciences Research towards Innovation and entrepreneurship.
(covilhã, Portugal)
|
2015/06 | Tackling S100B in Multiple Sclerosis. | Neuroscience Seminars. IMM, FMULisboa
(Lisboa, Portugal)
|
2015/03 | S100B: a new crucial player in Multiple Sclerosis. | VI Jornadas Nacionais de Ciências Biomédicas, Universidade Algarve,
(Faro, Portugal)
|
Supervision
Thesis Title Role |
Degree Subject (Type) Institution / Organization |
|
---|---|---|
2024 - Current | Avanços na investigação sobre linfomas: do diagnóstico à terapia
Supervisor
|
Análises Clínicas (Master)
Universidade de Lisboa Faculdade de Farmácia, Portugal
|
2024 - Current | Envolvimento do sistema nervoso central (SNC) em neoplasias malignas hematológicas
Supervisor
|
Análises Clínicas (Master)
Universidade de Lisboa Faculdade de Farmácia, Portugal
|
2024 - Current | Linfoma Nodal da Zona Marginal – O peso dos critérios morfológicos, fenotípicos e clínicos no diagnóstico da doença, análise
retrospetiva
Co-supervisor
|
Análises Clínicas (Master)
Universidade de Lisboa Faculdade de Farmácia, Portugal
|
2023 - Current | Investigating Microglia-T Cell Interactions and Demyelination in a 3D Brainsphere Model of Multiple Sclerosis: Development
of new therapeutic Strategies
Supervisor
|
Farmácia (PhD)
Universidade de Lisboa Faculdade de Farmácia, Portugal
|
2023 - Current | Cerebral spinal fluid and plasma biomarkers in late-onset Spinal Muscular Atrophy patients treated with Nusinersen
Supervisor
|
Ciências Biofarmacêuticas (Master)
Universidade de Lisboa Faculdade de Farmácia, Portugal
|
2023 - Current | Hericium erinaceus polyphenolic and polysaccharides on the strive against Alzheimer’s Disease
Supervisor
|
Qualidade Alimentar e Saúde (Master)
Universidade de Lisboa Faculdade de Farmácia, Portugal
|
2022/01/01 - Current | Deciphering the role of microglia-T cells interplay upon viral infection: impact in Multiple Sclerosis progression
Supervisor
|
Farmácia (PhD)
Universidade de Lisboa Faculdade de Farmácia, Portugal
|
2022/01/01 - Current | Nanovaccine for oral immunisation to break the link between periodontitis and Alzheimer’s disease
Supervisor
|
Farmácia (PhD)
Universidade de Lisboa Faculdade de Farmácia, Portugal
|
2022/01/01 - Current | BDNF receptor cleavage in Alzheimer's disease: unveiling the impact on microglia
Co-supervisor
|
Programa Doutoral do Centro Académico de Medicina de Lisboa (ramo de Medicina; ramo de Ciências Biomédicas; ramo de Ciências
e Tecnologias da Saúde) (PhD)
Universidade de Lisboa Faculdade de Medicina, Portugal
|
2022 - Current | Avaliação do risco cardiovascular em doentes com hiperferritinemia
Supervisor
|
Análises Clínicas (Master)
Universidade de Lisboa Faculdade de Farmácia, Portugal
|
2022/10/01 - 2023/11 | New in vitro model of microglia-derived from human PBMCs to unravel their contribution in neurodegenerative disorders
Supervisor
|
Ciências Biofarmacêuticas (Master)
Universidade de Lisboa Faculdade de Farmácia, Portugal
|
2022/01/01 - 2023/05/31 | Innovative platform for in vivo imaging of myelin clearance during Multiple Sclerosis progression
Supervisor
|
Farmácia (PhD)
Universidade de Lisboa Faculdade de Farmácia, Portugal
|
2022 - 2023 | Mieloma Múltiplo: do Diagnóstico à Terapêutica
Supervisor
|
Análises Clínicas (Master)
Universidade de Lisboa Faculdade de Farmácia, Portugal
|
2022 - 2023 | O papel da microglia no desenvolvimento da Esclerose Múltipla
Supervisor
|
Análises Clínicas (Master)
Universidade de Lisboa Faculdade de Farmácia, Portugal
|
2021 - 2023 | Terapêutica com células CAR-T: Novas Aplicações Terapêuticas em Doenças Hematológicas
Supervisor
|
Análises Clínicas (Master)
Universidade de Lisboa Faculdade de Farmácia, Portugal
|
2019 - 2023 | Deciphering the role of neuroinflammation in the psycho-pathology and frailty index of multiple sclerosis
Supervisor of Ana Rita Ribeiro
|
Farmácia (PhD)
Universidade de Lisboa Faculdade de Farmácia, Portugal
|
2021/10/01 - 2022/12 | Detection of Age-associated Changes of the Targets of Disease Modifying Therapies in Multiple Sclerosis
Supervisor
|
Ciências Biofarmacêuticas (Master)
Universidade de Lisboa Faculdade de Farmácia, Portugal
|
2021/10/01 - 2022/12 | Neuronal and behavioral alterations after intake of N-ethylpentylone in CD-1 mice
Supervisor
|
Ciências Biofarmacêuticas (Master)
Universidade de Lisboa Faculdade de Farmácia, Portugal
|
2020/09/01 - 2021/11/09 | Effects of Newly Detected Synthetic Cathinones on the Central Nervous System
Supervisor
|
Ciências Biofarmacêuticas (Master)
Universidade de Lisboa Faculdade de Farmácia, Portugal
|
2019/09 - 2021/03 | The impact of BDNF receptor cleavage in Alzheimer’s disease-associated Neuroinflammation.
Supervisor of Mafalda Manso
|
Bioquímica (Master)
Universidade de Lisboa Faculdade de Ciências, Portugal
|
2019/09 - 2021/01/29 | Organotypic brain slice cultures as a model to study supressors of amyloid-ß toxicity relevant in Alzheimer’s disease.
Co-supervisor
|
Bioquímica (Master)
Universidade de Lisboa Faculdade de Ciências, Portugal
|
2019/09 - 2021/01 | Role of CNS cells in ischemia-reperfusion lesion associated with stroke.
Co-supervisor of Sofia Santos
|
Ciências Biofarmacêuticas (Master)
Universidade de Lisboa Faculdade de Farmácia, Portugal
|
2019/09 - 2020/12/17 | Tackling the role of S100B and associated neuroinflammation in an ex vivo demyelinating model.
Supervisor
|
Biologia Celular e Molecular (Master)
Universidade de Coimbra Faculdade de Ciencias e Tecnologia, Portugal
|
2018 - 2020/06/05 | Role of S100B in EAE pathogenesis
Supervisor
|
Neurociências (Master)
Universidade de Lisboa Faculdade de Medicina, Portugal
|
2018 - 2019/10 | BASHY dyes for characterization of demyelination and possible microglia targeting
Supervisor
|
Genética Molecular e Biomedicina (Master)
Universidade Nova de Lisboa Faculdade de Ciências e Tecnologia, Portugal
|
2017 - 2019 | Benefits of targeting microRNAs to prevent AD-related neurodegeneration and inflammation by cell-derived exosomes
Co-supervisor
|
Ciências Biofarmacêuticas (Master)
Universidade de Lisboa Faculdade de Farmácia, Portugal
|
2014 - 2019 | The role of S100B in Multiple Sclerosis: from a biomarker to a therapeutic target
Supervisor of Andreia Barateiro
|
|
2013/09/01 - 2018/04/04 | DECIPHERING THE INVOLVEMENT OF S100B-RAGE AXIS IN INFLAMMATION-ASSOCIATED MYELIN DAMAGE
Supervisor of Gisela Santos
|
Farmácia (PhD)
Universidade de Lisboa Faculdade de Farmácia, Portugal
|
2017 - 2018 | Target S100B to reduce Experimental Autoimmune Encephalomyelitis pathogenesis
Supervisor of Catarina da Silva Barros
|
Ciências Biofarmacêuticas (Master)
Universidade de Lisboa Faculdade de Farmácia, Portugal
|
2017 - 2018 | Vesicular Trafficking in Alzheimer’s Disease
Co-supervisor of Sofia Gravanita Ferreira
|
Genética Molecular e Biomedicina (Master)
Universidade Nova de Lisboa Faculdade de Ciências e Tecnologia, Portugal
|
2016 - 2017 | S100B targeting to reduce demyelination and EAE pathogenesis
Supervisor of Pedro Filipe Marques Pascoal
|
Ciências Biofarmacêuticas (Master)
Universidade de Lisboa Faculdade de Farmácia, Portugal
|
2016 - 2017 | Dissecting deregulated cell-to-cell communication in in vitro Alzheimer’s Disease models
Co-supervisor
|
Genética Molecular e Biomedicina (Master)
Universidade Nova de Lisboa Faculdade de Ciências e Tecnologia, Portugal
|
2011 - 2017 | Evaluation of neuroprotective and neurotoxic functions of different microglia phenotypes in Alzheimer’s disease onset and
progression, using in-vitro and in-vivo models
Co-supervisor of Claudia Caldeira
|
Farmácia (PhD)
Universidade de Lisboa Faculdade de Farmácia, Portugal
|
2014 - 2016 | Role of microRNA in microglial phenotype during the progression of Alzheimer’s disease
Supervisor of Mafalda Aurélio Monteiro
|
Ciências Biofarmacêuticas (Master)
Universidade de Lisboa Faculdade de Farmácia, Portugal
|
2014 - 2015 | Modulation of microglia reactivity by S100B in Multiple Sclerosis
Supervisor of Carla Isabel Silveira Ferreira
|
Ciências Biofarmacêuticas (Master)
Universidade de Lisboa Faculdade de Farmácia, Portugal
|
2012 - 2014 | Role of S100B on central nervous system demyelination and remyelination
Supervisor of Vera Alexandra Padrela Martins Afonso
|
Ciências Biofarmacêuticas (Master)
Universidade de Lisboa Faculdade de Farmácia, Portugal
|
2008 - 2012 | Bilirubin dysregulates myelination in early neonatal life
Co-supervisor of Andreia Barateiro
|
Farmácia (PhD)
Universidade de Lisboa Faculdade de Farmácia, Portugal
|
Event organisation
Event name Type of event (Role) |
Institution / Organization | |
---|---|---|
2019 - Current | XIV European Meeting on Glial Cells in Health and Disease - Local organizing committee (2019)
Congress (Member of the Organising Committee)
|
|
2019 - Current | IV Symposium of the Portuguese Glial Network - organizing committee (2019)
Symposium (Member of the Organising Committee)
|
Universidade de Lisboa Faculdade de Farmácia, Portugal |
2019 - Current | Cientificamente Provável, the participation of iMed.ULisboa in this initiative has been contributing to the promotion of scientific
literacy and enrichment of the training path of young people, motivating them to deepen their knowledge and pursue higher
studies in their areas of interest.
(2019/05/03)
Workshop (Member of the Organising Committee)
|
Universidade de Lisboa Instituto de Investigação do Medicamento, Portugal Universidade de Lisboa Faculdade de Farmácia, Portugal |
2010 - Current | Brain Awareness Week - Dissemination of Neuroscience Science to elementary and high school students under the Brain Awareness
Week initiative created by the Dana Foundation, USA, which aims to raise awareness of the general public, including students,
for the progress and benefit of brain study.
(2021/03/15 - 2021/03/19)
Seminar (Co-organisor)
|
Universidade de Lisboa Instituto de Investigação do Medicamento, Portugal Universidade de Lisboa Faculdade de Farmácia, Portugal |
2024/06/25 - 2024/06/29 | Symposium of the FENS Forum 2024- "Diverse glial contribution to demyelination and Multiple Sclerosis" (2024/06/25 - 2024/06/29)
Symposium (President of the Organising Committee)
|
Universidade de Lisboa Instituto de Investigação do Medicamento, Portugal Universidade de Lisboa Faculdade de Farmácia, Portugal |
2023/07 - 2023/07 | SCIENTIFIC OCCUPATION OF YOUNG PEOPLE ON VACATION 2023, by Ciência Viva (2023/07 - 2023/07)
Workshop (President of the Organising Committee)
|
Universidade de Lisboa Faculdade de Farmácia, Portugal Universidade de Lisboa Instituto de Investigação do Medicamento, Portugal |
2022/07 - 2022/07 | SCIENTIFIC OCCUPATION OF YOUNG PEOPLE ON VACATION 2022, by Ciência Viva (2022/07 - 2022/07)
Workshop (President of the Organising Committee)
|
Universidade de Lisboa Instituto de Investigação do Medicamento, Portugal Universidade de Lisboa Faculdade de Farmácia, Portugal |
2021/07 - 2021/07 | SCIENTIFIC OCCUPATION OF YOUNG PEOPLE ON VACATION 2021, by Ciência Viva (2021/07 - 2021/07)
Workshop (President of the Organising Committee)
|
Universidade de Lisboa Instituto de Investigação do Medicamento, Portugal Universidade de Lisboa Faculdade de Farmácia, Portugal |
2014/11 - 2014/11 | Profiling alterations in microglia dynamic properties by neuroinflammation (2014/11)
Workshop
|
Universidade de Lisboa Instituto de Investigação do Medicamento, Portugal |
2012/10 - 2012/10 | Myelin: genesis, disease and repair (2012/10 - 2012/10)
Symposium (President of the Organising Committee)
|
Universidade de Lisboa Instituto de Investigação do Medicamento, Portugal |
2012/02 - 2012/02 | xCELLigence System On Your Campus (2012/02 - 2012/02)
Workshop (President of the Organising Committee)
|
Universidade de Lisboa Instituto de Investigação do Medicamento, Portugal |
Jury of academic degree
Topic Role |
Candidate name (Type of degree) Institution / Organization |
|
---|---|---|
2023/12 | Investigations of S100 proteins and their role in huntingtin aggregation
(Thesis) Main arguer
|
Marta Sofia Silva da Cruz Botelho (Master)
Universidade de Lisboa Faculdade de Ciências, Portugal
|
2023/12 | Comparative Efficacy of CK1 Inhibitors and miRNA
loaded Exosomes on the Recovery
of ALS Injured Microglia
(Thesis) Main arguer
|
Rita Jorge Barbosa (Master)
Universidade de Lisboa Faculdade de Farmácia, Portugal
|
2023/12 | Mieloma Múltiplo: do Diagnóstico à Terapêutica
Supervisor
|
Rita Margarida Madeira Gonçalves (Master)
Universidade de Lisboa Faculdade de Farmácia, Portugal
|
2023/11 | Terapêutica com células CAR-T: Novas Aplicações Terapêuticas em Doenças Hematológicas
Supervisor
|
Carolina Miki Sakamoto Tasca (Master)
Universidade de Lisboa Faculdade de Farmácia, Portugal
|
2023/11 | New in vitro model of microglia derived from human PBMCs to unravel their contribution in neurodegenerative disorders
Supervisor
|
Inês Sofia Tomaz da Costa (Master)
Universidade de Lisboa Faculdade de Farmácia, Portugal
|
2023/11 | O papel da microglia no desenvolvimento da Esclerose Múltipla
Supervisor
|
Rita Alexandra Andrade da Cruz Soares Ramos (Master)
Universidade de Lisboa Faculdade de Farmácia, Portugal
|
2023/11 | Aplicação de nanopartículas metálicas no tratamento do cancro da próstata
President of the jury
|
Sara Inês Bastos Pinho (Master)
Universidade de Lisboa Faculdade de Farmácia, Portugal
|
2023/11 | Contaminantes nos Alimentos - Microplásticos
President of the jury
|
Mafalda Inês Domingos Potier (Master)
Universidade de Lisboa Faculdade de Farmácia, Portugal
|
2023/11 | Formulation, characterization and stability studies of emulsions containing different vegetable oils and caffeine as active
compound
President of the jury
|
Ana Margarida Colaço Dionísio (Master)
Universidade de Lisboa Faculdade de Farmácia, Portugal
|
2023/07 | Investigation of novel compounds to prevent TrkB-FL cleavage
(Thesis) Main arguer
|
Lia Marta Barreira Fernandes (Master)
Universidade de Lisboa Faculdade de Medicina, Portugal
|
2023/06 | Microglia depletion impact in epileptogenesis Focusing on NLRP3 inflammasome pathways
(Thesis) Main arguer
|
Carolina Maria Vieira Capela (Master)
Universidade de Lisboa Instituto Superior Técnico, Portugal
|
2023/02/10 | Developing molecular tools for the study of the STAT3 pathway
(Thesis) Arguer
|
Ricardo Letra-Vilela (PhD)
Universidade Nova de Lisboa Faculdade de Ciências e Tecnologia, Portugal
|
2022/12/20 | ROLE OF SP1 AND PADI2 ON OLIGODENDROCYTE DIFFERENTIATION ENHANCED BY MECHANOTRANSDUCTION
(Thesis) Main arguer
|
Tânia Milene Pires Lourenço (PhD)
Universidade de Coimbra Instituto de Investigação Interdisciplinar, Portugal
|
2022/12/19 | Detection of age-associated changes of the targets of disease modifying therapies in Multiple Sclerosis
Supervisor
|
Raquel Rei Pereira (Master)
Universidade de Lisboa Faculdade de Farmácia, Portugal
|
2022/12/13 | Neuronal and behavioral alterations after intake of N-ethylpentylone in CD-1
Supervisor
|
Catarina Isabel Venda Grilo (Master)
Universidade de Lisboa Faculdade de Farmácia, Portugal
|
2022/07/20 | Deadly Delivery: Unraveling the Contribution of Microglial Exosomes to Retinal Degeneration in Glaucoma
(Thesis) Arguer
|
Inês Sofia Dinis Aires (PhD)
Universidade de Coimbra Faculdade de Medicina, Portugal
|
2022/07/04 | Search for novel compounds to prevent TrkB-FL cleavage
(Thesis) Main arguer
|
Sara Inteiro de Oliveira (Master)
Universidade de Lisboa Faculdade de Medicina, Portugal
|
2022/06/03 | Mechanical principles driving microglia activation
(Thesis) Main arguer
|
Pedro Neves Melo (PhD)
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
|
2022/04/29 | DIFFERENTIAL ROLE OF PGC-1a ISOFORMS IN THE MODULATION OF ASTROCYTES REACTIVE PHENOTYPE
(Thesis) Main arguer
|
CARLOTA DE SÁ LEMOS GARCIA (Master)
Universidade Nova de Lisboa Faculdade de Ciências e Tecnologia, Portugal
|
2021/12/10 | Exploring cognition, 4-octyl itaconate treatment and clinical scoring in the animal model of Multiple Sclerosis, Experimental
Autoimmune Encephalomyelitis
(Thesis) Main arguer
|
Maria Inês Portela de Melo (Master)
Universidade do Porto Faculdade de Medicina, Portugal
|
2021/12/10 | Can the extracellular vesicles released by Müller glial cells provide neuroprotection to retinal ganglion cells?
(Thesis) Main arguer
|
Carolina Marques dos Santos (Master)
Universidade de Coimbra Faculdade de Medicina, Portugal
|
2021/12/09 | Development of new pharmacological approaches in ischemic stroke: A Systematic Review of transient MCAO model in rats.
(Thesis) Arguer
|
João Solas (Master)
Universidade de Lisboa Faculdade de Farmácia, Portugal
|
2021/11/09 | Effects Of Newly Detected Synthetic Cathinones On The Central Nervous System
Supervisor
|
Ana Margarida Barata Leitão (Master)
Universidade de Lisboa Faculdade de Farmácia, Portugal
|
2021/07/19 | Bacteriological etiology of Alzheimer’s Disease: Possibility of a vaccine?
(Thesis) Main arguer
|
Alexandra Filipa Neves Gomes (Master)
Universidade de Lisboa Faculdade de Farmácia, Portugal
|
2021/07/01 | Characterization of BDNF signalling in the neonatal phencyclidine mouse model of schizophrenia
(Thesis) Main arguer
|
Céline Felicidade Freitas (Master)
Universidade de Lisboa Faculdade de Medicina, Portugal
|
2021/06/25 | Characterization of the Cancer Antigen Release Profile of Nanoparticle-based Immunotherapy
(Thesis) Arguer
|
Maria Machado Rodrigues González (Other)
Universidade Nova de Lisboa Faculdade de Ciências e Tecnologia, Portugal
|
2021/06/25 | Development of nanoparticle-based immunotherapy using chitosan as an immunomodulator
(Thesis) Arguer
|
Pedro Lino Rosado (Other)
Universidade Nova de Lisboa Faculdade de Ciências e Tecnologia, Portugal
|
2021/06/22 | Unveiling the link between BDNF alterations and cognitive deficits in Schizophrenia
(Thesis) Arguer
|
Sara Luísa Ramalho Tanqueiro (PhD)
Universidade de Lisboa Faculdade de Medicina, Portugal
|
2021/06/20 | Determining the Cellular and Molecular Mechanisms Behind Glial Cell Phagocytosis
(Thesis) Arguer
|
Lynn Nazareth (PhD)
School of Pharmacy and Medical Science, Griffith Health, Griffith University, Australia
|
2021/03/22 | Unravelling the contribution of glial cells for the neuroinflammatory milieu of epileptic-like organotypic slices
(Thesis) Arguer
|
Mafalda Cagica Pinto de Carvalho (Master)
Universidade de Lisboa Faculdade de Ciências, Portugal
|
2021/03/18 | The impact of BDNF receptor cleavage in Alzheimer’s disease-associated Neuroinflammationn
Supervisor
|
Mafalda Manso (Master)
Universidade de Lisboa Faculdade de Ciências, Portugal
|
2021/03/18 | The impact of BDNF receptor cleavage in Alzheimer’s disease-associated Neuroinflammation
Supervisor
|
Mafalda Ferreira Manso (Master)
Universidade de Lisboa Faculdade de Ciências, Portugal
|
2021/01/30 | Organotypic brain slice cultures as a model to study supressors of Amyloid-ß toxicity relevant in Alzheimer’s Disease
Supervisor
|
Francisco Schäller Dias (Master)
Universidade de Lisboa Faculdade de Ciências, Portugal
|
2021/01/14 | Neuronal miR-124 in Alzheimer's Disease human models: from cell functioning to trafficking
(Thesis) Arguer
|
Henrique Paulino Sasso Pereira Mamede (Master)
Universidade de Lisboa Instituto Superior Técnico, Portugal
|
2020/12/17 | Gene deletion and nanobodies strategies to target S100B and improve recovery in an ex vivo demyelinating model
Supervisor
|
Alexandre Nunes Neto (Master)
Universidade de Coimbra Faculdade de Ciencias e Tecnologia, Portugal
|
2020/12 | Wound Healing: The role of Exosomes
(Thesis) Main arguer
|
Júlia Carolina Lopes Matos (Master)
Universidade de Lisboa Faculdade de Farmácia, Portugal
|
2020/12 | Linfoma de Hodgkin. Diagnóstico e terapêuticas atuais
(Thesis) Main arguer
|
Nuno Manuel Cepeda da Silva (Master)
Universidade de Lisboa Faculdade de Farmácia, Portugal
|
2020/11 | Leucemia Linfocítica Crónica Diagnóstico e terapêutica: Novas abordagens
(Thesis) Main arguer
|
Maria João Correia Goulart (Master)
Universidade de Lisboa Faculdade de Farmácia, Portugal
|
2020/11 | Mieloma Múltiplo: Diagnóstico e Terapêutica. Novos Marcadores da Doença
(Thesis) Main arguer
|
Ana Margarida Murteira Damásio Boieiro Cotovio (Master)
Universidade de Lisboa Faculdade de Farmácia, Portugal
|
2020/06/05 | Role of S100B in EAE pathogenesis
Supervisor
|
Beatriz dos Santos Pinto Soromenho (Master)
Universidade de Lisboa Faculdade de Medicina, Portugal
|
2020/02/17 | Evaluating cortical transcriptomic differences between Alzheimer’s disease PSEN1-mutated mouse models and human patients,
and their implications in drug development
(Thesis) Arguer
|
Sara Rodrigues Mendes (Master)
Universidade de Lisboa Faculdade de Farmácia, Portugal
|
2020/01/21 | TUNING CELL DEATH AND INFLAMMATION IN PARKINSON’S DISEASE
(Thesis) Arguer
|
Pedro Dionísio (PhD)
Universidade de Lisboa Faculdade de Farmácia, Portugal
|
2020/01/13 | Characterization of blood markers and
their implication in human aging
(Thesis) Main arguer
|
Ainhoa Alberro Garitano (PhD)
Universidad del País Vasco, Spain
|
2019/12/12 | Impact of the Modulation of Tumor Vasculature on Cancer Vaccine Efficacy against Colorectal Cancer
(Thesis) Arguer
|
Sandra Pena (Master)
Universidade de Lisboa Faculdade de Farmácia, Portugal
|
2019/11/19 | Implication of induced Reelin-KO in the deposition of Aß plaques in Alzheimer´s Disease mouse models
(Thesis) Main arguer
|
Rita Patrocínio (Master)
Universidade de Lisboa Instituto Superior Técnico, Portugal
|
2019/11/06 | Vectored immunoprophylaxis to produce anti-BACE1
nanobodies for treatment of Alzheimer’s disease
(Thesis) Main arguer
|
Eugénia Machado (Master)
Universidade de Lisboa Faculdade de Ciências, Portugal
|
2019/09/10 | MICROGLIA-MEDIATED REMODELLING OF THE
CEREBELLAR CIRCUIT
(Thesis) Main arguer
|
Pedro Ferreira (Master)
Universidade de Coimbra Faculdade de Ciencias e Tecnologia, Portugal
|
2019/07/25 | Dissecting pentraxin-3 role in the modulation
of Multiple Sclerosis
(Thesis) Main arguer
|
Joana Lima Sá (Master)
Universidade do Minho Escola de Medicina, Portugal
|
2019/07/25 | The potential role of innate immune memory in Multiple Sclerosis disease using autoimmune experimental encephalomyellitis
mouse model
(Thesis) Main arguer
|
Marta Monteiro (Master)
Universidade do Minho Escola de Medicina, Portugal
|
2019/06/18 | The calcium binding S100B protein as a new modulator of amyloid-ß peptide aggregation
(Thesis) Arguer
|
Joana Cristóvão (PhD)
Universidade de Lisboa Faculdade de Ciências, Portugal
|
2019 | UNVEILLING THE INTERPLAY BETWEEN ACTIVATED ASTROCYTES AND NEURONS IN AN IN VITRO MODEL OF ALZHEIMER’S DISEASE
Supervisor
|
Ana Filipa da Costa Moreira (Master)
Universidade de Lisboa Faculdade de Farmácia, Portugal
|
2018 | Deciphering the involvement of S100B-RAGE axis in inflammation-associated myelin damage
Supervisor
|
Gisela Filipa Assunção Santos (PhD)
Universidade de Lisboa Faculdade de Farmácia, Portugal
|
2018 | Mechanisms of actin cytoskeletal dynamics in
oligodendrocyte biology and myelin formation
(Thesis) Main arguer
|
Maria Manuela Azevedo (PhD)
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
|
2018 | Targeting mitochondria-nucleus communication to improve aging-impaired neurogenesis
(Thesis) Main arguer
|
Marcia Filipa Freire Dias da Costa (Master)
Universidade de Lisboa Faculdade de Farmácia, Portugal
|
2018 | Changes in Erythropoiesis and Transferrin Receptor 2 in Malaria-induced Anemia
(Thesis) Main arguer
|
Ana Catarina Guilherme Pêgo (Master)
Universidade de Lisboa Faculdade de Farmácia, Portugal
|
2018 | TARGETING MIR-124 IN MOTOR NEURONS AS A THERAPEUTIC STRATEGY TO PREVENT NEURODEGENERATION AND GLIAL ACTIVATION IN ALS
(Thesis) Main arguer
|
Daniela Catarina Ribeiro Vizinha (Master)
Universidade de Lisboa Faculdade de Farmácia, Portugal
|
2018 | Role of adenosine A2A Receptors in Multiple Sclerosis:
Neural Stem Cells as a potential target
(Thesis) Main arguer
|
Ana Marta Alonso Gomes (Master)
Universidade de Lisboa Instituto Superior Técnico, Portugal
|
2018 | Astrocyte-specific Transcriptomic Response to PGC-1alpha Isoforms
(Thesis) Main arguer
|
Mariana Messias de Jesus Rufino Ribeiro (Master)
Universidade de Lisboa Faculdade de Farmácia, Portugal
|
2017 | S100B targeting to reduce demyelination and EAE pathogenesis
Supervisor
|
Pedro Filipe Marques Pascoal (Master)
Universidade de Lisboa Faculdade de Farmácia, Portugal
|
2017 | Visualization of STAT3 dimers in living cells
(Thesis) Main arguer
|
Ana Catarina da Silva Almeida (Master)
Universidade de Lisboa Faculdade de Farmácia, Portugal
|
2016 | Role of microRNA in microglial phenotype during the progression of Alzheimer’s disease
Supervisor
|
Mafalda Aurélio Monteiro (Master)
Universidade de Lisboa Faculdade de Farmácia, Portugal
|
2015 | Impact of Mechanotransduction in the Context of Central Nervous System Diseases
(Thesis) Main arguer
|
Daniela Nogueira da Rocha Mar (PhD)
Universidade do Porto Faculdade de Engenharia, Portugal
|
2015 | Modulation of microglia reactivity by S100B in Multiple Sclerosis
Supervisor
|
Carla Isabel Silveira Ferreira (Master)
Universidade de Lisboa Faculdade de Farmácia, Portugal
|
2015 | Exploring the modulatory role of A2A receptors in oligodendrogenesis derived from neural stem/progenitor cells of the subventricular
zone
(Thesis) Main arguer
|
Ana Iolanda d’Armada Moreira (Master)
Universidade de Lisboa Faculdade de Medicina, Portugal
|
2014 | Role of S100B on central nervous system demyelination and remyelination
Supervisor
|
Vera Alexandra Padrela Martins Afonso (Master)
Universidade de Lisboa Faculdade de Farmácia, Portugal
|
2014 | Organotypic Hippocampal Slice Culture Model of Epileptogenesis: Electrophysiological and Molecular Features
(Thesis) Main arguer
|
Noémia Marisa Felix Pereira (Master)
Universidade de Lisboa Faculdade de Medicina, Portugal
|
2012 | Bilirubin dysregulates myelination in early neonatal life
Supervisor
|
Andreia Pereira Barateiro (PhD)
Universidade de Lisboa Faculdade de Farmácia, Portugal
|
Association member
Society Organization name | Role | |
---|---|---|
2016 - Current | Portuguese Glia Network | Outreach team |
2008 - Current | Portuguese Society of Neurosciences | |
2008 - Current | Federation of European Neuroscience Societies | |
2002/04/01 - Current | Ordem dos Farmacêuticos |
Conference scientific committee
Conference name | Conference host | |
---|---|---|
2019 - Current | XVI Meeting of the Portuguese Society for Neuroscience | |
2019 - Current | XIV European Meeting on Glial Cells in Health and Disease |
Course / Discipline taught
Academic session | Degree Subject (Type) | Institution / Organization | |
---|---|---|---|
2022 - Current | Master Laboratory Medicine | Análises Clínicas (Mestrado integrado) | Universidade de Lisboa Faculdade de Farmácia, Portugal |
2020/07/06 - Current | Advances in Neuropharmaceutics | Farmácia | Universidade de Lisboa Faculdade de Farmácia, Portugal |
2017 - Current | Master in Biochemistry | (Mestrado) | Universidade de Lisboa Faculdade de Ciências, Portugal |
2015 - Current | Master/PhD in Neurosciences | (Mestrado) | Universidade de Lisboa Faculdade de Medicina, Portugal |
2012 - Current | Master in Biopharmaceutical Sciences: Development and Organization of the Nervous System, Neuropathology and Neuropharmacology, Brain Barriers and Drug development, Physiopathology of Neuroinflammation (Regency). | (Mestrado) | Universidade de Lisboa Faculdade de Farmácia, Portugal |
2010 - Current | Master in Pharmaceutical Chemistry and Therapeutics: Pharmaceutical Chemistry II | (Mestrado) | |
2009 - Current | Integrated master degree in Pharmaceutical Sciences: Anatomy, Biology Laboratory, Histology, Hematology. | master (Mestrado integrado) | Universidade de Lisboa Faculdade de Farmácia, Portugal |
2015 - 2020 | Molecular Biomarkers and Technologies | Farmácia (Doutoramento) | Universidade de Lisboa Faculdade de Farmácia, Portugal |
2016 - 2016 | PhD Programme GABBA | (Curso de doutoramento (conclusão de unidades curriculares)) | Universidade do Porto Instituto de Investigação e Inovação em Saúde, Portugal |
2014 - 2015 | PhD Programme Human Genetics and Infectious Diseases | (Curso de doutoramento (conclusão de unidades curriculares)) | Universidade Nova de Lisboa Faculdade de Ciências Médicas, Portugal |
Evaluation committee
Activity description Role |
Institution / Organization | Funding entity | |
---|---|---|---|
2024 - Current | ERA4HEALTH_NUTRIBRAIN
Evaluator
|
||
2023 - Current | MSCA POSTDOCTORAL FELLOWSHIPS 2023
Evaluator
|
European Commission, Belgium | |
2016 - Current | Alzheimer's Association – Call for Alzheimer's Association Research Grant (AARG)
Evaluator
|
||
2015 - Current | Italian Ministry of Health, Scientific Research and Health Innovation - Call for Research | ||
2014 - Current | MS Research Australia -Research projects
Evaluator
|
||
2019 - 2019 | Austrian Research Projects 2019
Evaluator
|
Fonds zur Förderung der wissenschaftlichen Forschung, Austria | |
2016 - 2016 | Israel Science Foundation
Evaluator
|
Israel Science Foundation, Israel | |
2015 - 2015 | Medical Research Council, UK
Evaluator
|
Medical Research Council, United Kingdom |
Mentoring / Tutoring
Topic | Student name | |
---|---|---|
2024/02 - Current | Treatment of innovative human 3D brainspheres with pentamidine to tackle the role of S100B in human demyelination | annelore Douven |
2023/01 - 2023/09 | Role of glial cells in the pathogenesis of Autosomal recessive spastic ataxia of Charlevoix-Saguenay (ARSACS) | Elisa Farsetti |
2022/10 - 2022/12 | Characterization of iMG to a demyelinating insult | Paula Hebing |
Distinctions
Award
2023 | Portuguese call for research projects 2023 - BIOCODEX MICROBIOTA FOUNDATION |
2022 | ARSACS Project -2022-2023
Ataxia Canada, Canada
|
2017 | Best Oral Communication at 4th International Porto Congress of Multiple Sclerosis
Merck KGaA, Germany
|
2017 | Grant for Multiple Sclerosis Innovation (GMSI)
Merck & Co Inc, United States
|
2013 | Bolsa Inovação da Secção Regional de Lisboa da Ordem dos Farmacêuticos
Ordem dos Farmaceuticos, Portugal
|
2012 | Edgar Cruz e Silva Prize
Grupo de Estudo de Envelhecimento Cerebral e Demências (GEECD), Portugal
|
2011 | Medal of Honor for Women in Science L’Oréal
Fundação para a Ciência e a Tecnologia, Portugal
UNESCO Office of International Standards and Legal Affairs, France Fondation L'Oréal, France |
2007 | EMBO short term felowship |
2002 | Programa Gulbenkian de Estímulo à Investigação
Fundação Calouste Gulbenkian, Portugal
|